Disc Medicine Highlights Clinical And Preclinical Data From BEACON And AURORA Trials Of Bitopertin And Phase 1 DISC-3405 Trial At ASH 2024, Showcasing Potential For Existing And New Indications While Advancing Pipeline Of Hematologic Disease Therapies
Disc Medicine Highlights Clinical And Preclinical Data From BEACON And AURORA Trials Of Bitopertin And Phase 1 DISC-3405 Trial At ASH 2024, Showcasing Potential For Existing And New Indications While Advancing Pipeline Of Hematologic Disease Therapies
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated